Genetic studies of T2D suggest that it is a multigenic disease in which common variants in multiple genes interact with environmental factors to cause the disease. 11–13 Because of the striking ...

WEDNESDAY, Sept. 11, 2024 (HealthDay News) -- People with a late chronotype have an increased risk for type 2 diabetes (T2D) and have higher body mass index (BMI) and larger waist circumference, ...

WEDNESDAY, Sept. 11, 2024 (HealthDay News) -- There is a reciprocal relationship between asthma and type 2 diabetes (T2D), according to a study presented at the annual meeting of the European ...

Medications for type 2 diabetes address different aspects of blood sugar management and are tailored to individual health needs. Navigating type 2 diabetes treatment options can be complex, but ...

Blurred vision, dry mouth, and frequent bathroom use are common signs of diabetes. If you’re experiencing these early signs, speaking with a doctor can help you manage your condition. Type 2 ...

Insulin efsitora alfa (efsitora) is a new basal insulin designed for once-weekly administration. Data on safety and efficacy have been limited to small, phase 1 or phase 2 trials. We conducted a ...

Individuals with type 2 diabetes (T2D) are more likely to develop asthma—and vice versa, according to an analysis of data on 17 million people presented at the annual meeting of the European ...

Around half of adults with diabetes (around 240 million worldwide) are unaware that they have the condition because the symptoms can be general or non-existent—around 90% of these have T2D.

Metformin treatment reduces the odds of worse inflammatory bowel disease (IBD) outcomes among individuals with concurrent IBD and type 2 diabetes (T2D), according to study findings published in ...

Intermittent fasting is a method for addressing excessive calorie intake by alternating between periods of eating and fasting. During the fasting period, which can last for 12-16 hours, all food ...

Insulet’s Omnipod ® 5 Automated Insulin Delivery (AID) System has been cleared by the Food and Drug Administration (FDA) for use in individuals aged 18 years and older with type 2 diabetes (T2D). This ...